Diabetes and Insulin Statistics
Understanding the Clinical Landscape of Diabetes Today
Provider Benefits
Explore the Pivot™ Benefits
Pivot's discreet, tubeless design and intuitive interface address common barriers to long-term pump use such as discomfort, fear of technology, and social stigma. With simplicity at our core, your patients are more likely to follow their therapy when it fits seamlessly into their lifestyle - allowing for patient satisfaction and sustained improvements in health markers.
Our design makes pump therapy a less intimidating option for a diverse range of patients, including T2D who are often underserved by traditional pumps. Our broad applicability means you can confidently recommend Pivot and simplify your decision-making process.
Our system provides digestible data on your patients insulin delivery, basal patterns and bolus history. This empowers you to make informed adjustments for better care outcomes.
We offer comprehensive support from our dedicated customer service, online tutorials, community forum and clinical training & education materials to support you and your patients.
Impact of Diabetes
The Growing Toll of Diabetes in America
Diabetes and its complications pose a growing public health crisis in the U.S., with far-reaching implications for individuals, health care systems, and society at large.4
The burden on the health care system is equally substantial. In 2020 alone, there were >7.8 million hospitalizations with diabetes as a listed diagnosis.1
On average, people with diagnosed diabetes have medical expenditures 2.6 times higher than would be expected without diabetes.5
At a societal level, the risk of diabetes and its complications is disproportionately higher for socially vulnerable groups, making it a critical issue for achievement of health equity.6
Health Care Provider Contact Form
Talk to One of Our Diabetes Educators to Get Started
- Centers for Disease Control and Prevention. National Diabetes Statistics Report, 2024. Centers for Disease Control and Prevention, U.S. Dept of Health and Human Services. Published June 2024. Accessed July 14, 2025. https://www.cdc.gov/diabetes/data/statistics-report/index.html
- Fang M, Wang D, Coresh J, Selvin E. Prevalence of diabetes by race and ethnicity in the United States, 2011–2018. N Engl J Med. 2021;384(24):2359-2368. doi:10.1056/NEJMsa2032271
- Pasquel FJ, Davis GM, Huffman DM, et al; for the Omnipod 5 SECURE-T2D Consortium. Automated insulin delivery in adults with type 2 diabetes: a nonrandomized clinical trial. JAMA Netw Open. 2024;7(6):e2459348. doi:10.1001/jamanetworkopen.2024.59348
- Patel SA. Diabetes complications in the U.S.: following the data to guide comprehensive action. Diabetes Care. 2025;48(1):15-17. doi:10.2337/dci24-0026
- Parker ED, Lin J, Mahoney T, Ume N, Yang G, Gabbay RA, et al. Economic costs of diabetes in the U.S. in 2022. Diabetes Care. 2024;47(1):26-43. doi:10.2337/dci23-0085
- Hill-Briggs F, Adler NE, Berkowitz SA, et al. Social determinants of health and diabetes: a scientific review. Diabetes Care. 2021;44(1):258-279. doi:10.2337/dci20-0053
- Citation: Emily D. Parker, Janice Lin, Troy Mahoney, Nwanneamaka Ume, Grace Yang, Robert A. Gabbay, Nuha A. ElSayed, Raveendhara R. Bannuru; Economic Costs of Diabetes in the U.S. in 2022. Diabetes Care 2 January 2024; 47 (1): 26–43. Doidoi.org/10.2337/dci23-0085
